cognitive cybersecurity intelligence

News and Analysis


Eisai Strikes Cancer Alliance to Line Up Potential Challenger to AstraZeneca Drug

Eisai is expanding the scope of its cancer drug pipeline through a partnership with Bliss Biopharmaceutical, whose lead program addresses a hot oncology target that makes it a potential competitor to a blockbuster AstraZeneca product.
Under the collaboration agreement announced Monday,…

Source: medcitynews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts

A National Imperative – Cyber Resiliency

Cybersecurity expert Andrea E. Davis emphasizes the increasing vulnerability of critical infrastructure to cyber threats, highlighting instances such as the 2003 US and Canada power